Skip to main contentSkip to navigation
Sirius Investors
Cyteir Therapeutics, Inc.

Cyteir Therapeutics, Inc.

CYT
NASDAQHealthcare

Revenue Analysis - CYT

Comprehensive quarterly and annual revenue breakdown by product lines and geographic regions to identify growth drivers and market opportunities.

CYT Corporation

Annual

Revenue by Product Line

Latest quarterly revenue breakdown by product segments

Quarterly Product Revenue

Product Revenue Details

Detailed breakdown of revenue by product line

Aerospace Materials

0.0% of total revenue

$261.5M

In Process Separation

0.0% of total revenue

$106.3M

Additive Technologies

0.0% of total revenue

$65.7M

Industrial Materials

0.0% of total revenue

$63.8M

Historical Revenue Data

Quarterly product revenue breakdown over time (Last 6 records)

Date
Additive Technologies
Aerospace Materials
In Process Separation
Industrial Materials
9/30/2015$65.7M$261.5M$106.3M$63.8M
6/30/2015$70.2M$264.8M$109.6M$63.6M
3/31/2015$69.7M$259.3M$107.3M$78.7M
12/31/2014$63.3M$244.7M$102.2M$75.8M
9/30/2014$67.5M$250.8M$108.2M$80.3M
6/30/2014$74.3M$262.4M$103.9M$86.5M

Revenue Trend Analysis

Analysis of major growing and declining segments based on recent revenue data

Product Segments

Stable Segments
Aerospace Materials-1.2%
In Process Separation-3.0%
Additive Technologies-6.4%

Earnings Reports

Want to see how CYT's earnings relate to revenue? View quarterly earnings results, EPS history, and earnings surprises to understand the company's profitability.

View Earnings Reports